Suramin demonstrates positive outcome in University of California ’s autism study

The University of California (UC) San Diego School of Medicine, US, has reported positive data from a small, randomised Phase I/II clinical trial (SAT1) of the 100-year-old drug ‘suramin’ to treat boys with autism spectrum disorder (ASD).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news